Nuvo Research Announces New Listing of Synera® Patent in FDA Orange Book
News Dec 27, 2012
Nuvo Research Inc. has announced that the United States Patent Office has granted the reinstatement of Patent No. 6,465,709 related to Synera® Patch (Synera Patent).
Nuvo has listed the Synera Patent in the U.S. Food and Drug Administration's (FDA) Orange Book.
The Orange Book listing requires an Abbreviated New Drug Application (ANDA) applicant seeking FDA approval for a generic version of Synera prior to expiration of the patent to notify Nuvo of its ANDA filing before it can obtain FDA approval.
"We are very pleased that we have received additional patent protection for Synera Patch in the U.S.," said Tina Loucaides, Nuvo's Vice-President and General Counsel.
Loucaides continued, "The listing of this patent in the FDA Orange Book provides us with significantly more years of protection and will allow us to better explore expanded indications for this unique topical local anesthetic patch."
Symmetry-breaking Method Opens Way for Bioactive CompoundsNews
EPFL chemists have developed a new catalytic method for symmetry breaking. Published in Angewandte Chemie, the method can help synthesize important building blocks for bioactive compounds such as anticancer drugs.READ MORE
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE